Suppr超能文献

验证功能扩散映射(fDMs)作为人类脑胶质瘤细胞密度的生物标志物。

Validation of functional diffusion maps (fDMs) as a biomarker for human glioma cellularity.

机构信息

Translational Brain Tumor Program, Medical College of Wisconsin, Milwaukee, Wisconsin, USA.

出版信息

J Magn Reson Imaging. 2010 Mar;31(3):538-48. doi: 10.1002/jmri.22068.

Abstract

PURPOSE

To present comprehensive examinations of the assumptions made in functional diffusion map (fDM) analyses and provide a biological basis for fDM classification.

MATERIALS AND METHODS

Sixty-nine patients with gliomas were enrolled in this study. To determine the sensitivity of apparent diffusion coefficients (ADCs) to cellularity, cell density from stereotactic biopsy specimens was correlated with preoperative ADC maps. For definition of ADC thresholds used for fDMs, the 95% confidence intervals (CI) for changes in voxel-wise ADC measurements in normal appearing tissue was analyzed. The sensitivity and specificity to progressing disease was examined using both radiographic and neurological criteria.

RESULTS

Results support the hypothesis that ADC is inversely proportional to cell density with a sensitivity of 1.01 x 10(-7) [mm(2)/s]/[nuclei/mm(2)]. The 95% CI for white matter = 0.25 x 10(-3) mm(2)/s, gray matter = 0.31 x 10(-3) mm(2)/s, a mixture of white and gray matter = 0.40 x 10(-3) mm(2)/s, and a mixture of white matter, gray matter, and cerebrospinal fluid = 0.75 x 10(-3) mm(2)/s. Application of these measurements as ADC thresholds produce varying levels of sensitivity and specificity to disease progression, which were all significantly better than chance.

CONCLUSION

This study suggests fDMs are valid biomarkers for brain tumor cellularity.

摘要

目的

全面检查功能扩散映射(fDM)分析中所做的假设,并为 fDM 分类提供生物学依据。

材料和方法

本研究纳入 69 例脑胶质瘤患者。为了确定表观扩散系数(ADC)对细胞密度的敏感性,对立体定向活检标本中的细胞密度与术前 ADC 图进行了相关性分析。为了确定用于 fDM 的 ADC 阈值,分析了正常组织中体素 ADC 测量值变化的 95%置信区间(CI)。使用影像学和神经学标准检查了疾病进展的敏感性和特异性。

结果

结果支持 ADC 与细胞密度成反比的假设,其敏感性为 1.01 x 10(-7) [mm(2)/s]/[nuclei/mm(2)]。95%CI 为白质= 0.25 x 10(-3) mm(2)/s,灰质= 0.31 x 10(-3) mm(2)/s,白质和灰质混合物= 0.40 x 10(-3) mm(2)/s,白质、灰质和脑脊液混合物= 0.75 x 10(-3) mm(2)/s。这些测量值作为 ADC 阈值的应用产生了不同水平的疾病进展敏感性和特异性,均明显优于随机水平。

结论

本研究表明 fDM 是脑肿瘤细胞密度的有效生物标志物。

相似文献

1
Validation of functional diffusion maps (fDMs) as a biomarker for human glioma cellularity.
J Magn Reson Imaging. 2010 Mar;31(3):538-48. doi: 10.1002/jmri.22068.
3
Longitudinal restriction spectrum imaging is resistant to pseudoresponse in patients with high-grade gliomas treated with bevacizumab.
AJNR Am J Neuroradiol. 2013 Sep;34(9):1752-1757. doi: 10.3174/ajnr.A3506. Epub 2013 Apr 11.

引用本文的文献

4
Impact of Sex Hormones on Glioblastoma: Sex-Related Differences and Neuroradiological Insights.
Life (Basel). 2024 Nov 21;14(12):1523. doi: 10.3390/life14121523.
6
Diffusion MRI is superior to quantitative T2-FLAIR mismatch in predicting molecular subtypes of human non-enhancing gliomas.
Neuroradiology. 2024 Dec;66(12):2153-2162. doi: 10.1007/s00234-024-03475-z. Epub 2024 Oct 8.
10
Brain diffusion MRI biomarkers after oncology treatments.
Rep Pract Oncol Radiother. 2024 Feb 16;28(6):823-834. doi: 10.5603/rpor.98728. eCollection 2023.

本文引用的文献

8
Evaluation of the functional diffusion map as an early biomarker of time-to-progression and overall survival in high-grade glioma.
Proc Natl Acad Sci U S A. 2005 Nov 15;102(46):16759-64. doi: 10.1073/pnas.0508347102. Epub 2005 Nov 2.
9
Functional diffusion map: a noninvasive MRI biomarker for early stratification of clinical brain tumor response.
Proc Natl Acad Sci U S A. 2005 Apr 12;102(15):5524-9. doi: 10.1073/pnas.0501532102. Epub 2005 Apr 1.
10
Quantitative comparison of algorithms for inter-subject registration of 3D volumetric brain MRI scans.
J Neurosci Methods. 2005 Mar 15;142(1):67-76. doi: 10.1016/j.jneumeth.2004.07.014.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验